Results 1 to 10 of about 4,239,487 (340)

Cellulitis: Treatment failure or failure to define treatment failure? [PDF]

open access: yesEmergency Medicine Australasia, 2020
Dear Editor, Cellulitis is a common ED diagnosis and antibiotics are part of routine management. Each year, almost 60 000 people are hospitalised for treatment of cellulitis in Australia, of which an estimated 11% were deemed preventable.1 Appropriate antibiotic selection involves the right antibiotic type, dosage and route of administration.
Nimai Etheridge, Gerben Keijzers
openaire   +3 more sources

Treatment failure in osteoporosis [PDF]

open access: yesOsteoporosis International, 2012
Guidelines concerning the definition of failure of therapies used to reduce the risk of fracture are provided.This study aims to provide guidelines concerning the definition of failure of therapies used to reduce the risk of fracture.A working group of the Committee of Scientific Advisors of the International Osteoporosis Foundation was convened to ...
Diez-Perez, A   +13 more
openaire   +4 more sources

Association of timing of percutaneous left ventricular assist device insertion with outcomes in patients undergoing cardiac surgeryCentral MessagePerspective

open access: yesJTCVS Open, 2023
Objectives: The aim of this study was to explore the associations between percutaneous ventricular assist device (pVAD) insertion timing relative to cardiac surgery and patient outcomes.
Jean-Luc A. Maigrot, BS   +5 more
doaj   +1 more source

M2-like macrophages exert hepatoprotection in acute-on-chronic liver failure through inhibiting necroptosis-S100A9-necroinflammation axis

open access: yesCell Death and Disease, 2021
Necroptosis has emerged as a novel and crucial player in acute and chronic liver diseases. Necroptotic cells lead to the release of DAMPs including S100A9, followed by the development of necroinflammation.
Li Bai   +5 more
doaj   +1 more source

Extracellular vesicles as potential biomarkers and treatment options for liver failure: A systematic review up to March 2022

open access: yesFrontiers in Immunology, 2023
IntroductionExtracellular vesicles (EVs) carrying functional cargoes are emerging as biomarkers and treatment strategies in multiple liver diseases. Nevertheless, the potential of EVs in liver failure remains indistinct.
Wang Lu   +9 more
doaj   +1 more source

Prognostic Value of Natriuretic Peptide Levels for Adverse Renal Outcomes in Patients With Moderate to Severe Acute Kidney Injury With or Without Heart Failure

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Natriuretic peptides have been recommended as biomarkers for the diagnosis and prognosis of patients with heart failure and are often elevated in the setting of acute kidney injury.
Thanat Chaikijurajai   +2 more
doaj   +1 more source

The level of NT-proBNP in ambulatory patients with chronic heart failure with preserved ejection fraction of the left ventricle [PDF]

open access: yesТерапевтический архив, 2018
The prevalence of chronic heart failure (CHF) remains high. Echocardiography is a reliable method of diagnosing heart failure. Determination of brain natriuretic peptide allows to identify patients with the most probable diagnosis of heart failure, which
V V Kirillova   +3 more
doaj   +1 more source

Study on the Relationship between the Levels of Trace Elements and Vitamins in Peripheral Blood of Patients with End-stage Liver Disease and the Etiology and Severity of Disease [PDF]

open access: yesZhongguo quanke yixue, 2022
Background Patients with end-stage liver disease such as liver cirrhosis and acute-on-chronic liver failure (ACLF) often have abnormal intake or absorption of trace elements and vitamins, but the relevant tests have not been popularized in clinic, the ...
Ming KONG, Manman XU, Yu CHEN
doaj   +1 more source

Heart failure drug treatment [PDF]

open access: yesThe Lancet, 2019
Heart failure is the most common cardiovascular reason for hospital admission for people older than 60 years of age. Few areas in medicine have progressed as remarkably as heart failure treatment over the past three decades. However, progress has been consistent only for chronic heart failure with reduced ejection fraction.
Patrick, Rossignol   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy